Alvotech
Latest news
Investors
16 April 2024
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Investors
03 April 2024
Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
Investors
22 March 2024